![Polpharma Header](https://www.pharmacompass.com/image/flap/polpharma-w32-desktop-headergif-32216.gif)
![Polpharma Header](https://www.pharmacompass.com/image/flap/polpharma-mobile-header-w32gif-11374.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/07/2895558/0/en/Seres-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://pharmaphorum.com/news/nestle-bids-take-control-seres-c-diff-drug-vowst
https://www.globenewswire.com/news-release/2024/06/06/2894527/0/en/Seres-Therapeutics-Enters-Into-Memorandum-of-Understanding-For-Vowst-Asset-Sale-to-Nestl%C3%A9-Health-Science.html
https://www.prnewswire.com/news-releases/nestle-health-science-agrees-to-acquire-global-rights-to-vowst-product-it-launched-in-june-2023-302165294.html
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/cdsco-panel-gives-nod-for-continuation-of-phase-ii-clinical-trial-of-siis-dengue-vaccine/110780564?utm_source=top_news&utm_medium=sectionListing